Throughout history, brilliant minds have tried to figure out the secret behind living longer. Much of the research has credited diet and exercise, but a group of scientists expanded on previous data ...

Blueprint Medicines Corporation BPMC announced that the FDA placed a partial clinical hold on the phase I/II study of pipeline candidate BLU-222. The company is developing investigational inhibitor, ...

(Toronto, November 14, 2025) A new study published in the Journal of Medical Internet Research reveals how “super users”—clinicians who lead the charge in adopting virtual health care tools—are ...

Blueprint Medicines Corporation BPMC announced top-line data from part 2 of the PIONEER study, which evaluated its marketed drug, Ayvakit (avapritinib) for treating patients with non-advanced systemic ...